94 related articles for article (PubMed ID: 12352913)
21. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
[TBL] [Abstract][Full Text] [Related]
22. Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipients.
Hung HC; Hsu PJ; Lee JC; Wang YC; Cheng CH; Wu TH; Wu TJ; Chou HS; Chan KM; Lee WC; Lee CF
Immun Inflamm Dis; 2021 Mar; 9(1):134-143. PubMed ID: 33145985
[TBL] [Abstract][Full Text] [Related]
23. [Cytomeglovirus infection after liver transplantation].
Qiu F; Lang R; Yang X
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):684-5. PubMed ID: 11769602
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies.
Muñoz-Cobo B; Solano C; Costa E; Bravo D; Clari MÁ; Benet I; Remigia MJ; Montoro J; Navarro D
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1602-11. PubMed ID: 21871245
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers.
Rao M; Finny GJ; Abraham P; Juneja R; Thomas PP; Jacob CK; Sridharan G
Nephron; 2000 Apr; 84(4):367-73. PubMed ID: 10754415
[TBL] [Abstract][Full Text] [Related]
26. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.
Bodro M; Sabé N; Lladó L; Baliellas C; Niubó J; Castellote J; Fabregat J; Rafecas A; Carratalà J
Liver Transpl; 2012 Sep; 18(9):1093-9. PubMed ID: 22532316
[TBL] [Abstract][Full Text] [Related]
28. Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
Boillat Blanco N; Pascual M; Venetz JP; Nseir G; Meylan PR; Manuel O
Transplantation; 2011 Jan; 91(2):251-5. PubMed ID: 21099744
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients.
Lisboa LF; Preiksaitis JK; Humar A; Kumar D
Transplantation; 2011 Nov; 92(9):1063-8. PubMed ID: 21878838
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.
Albano MS; Ciubotariu R; Dobrila L; Tarnawski M; DeLeon M; Watanabe C; Krishnan S; Scaradavou A; Rubinstein P
Transfusion; 2017 Nov; 57(11):2768-2774. PubMed ID: 28758211
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two molecular assays for detection of cytomegalovirus DNA in whole blood and plasma samples from transplant recipients.
Costa C; Sidoti F; Mantovani S; Gregori G; Proietti A; Ghisetti V; Cavallo R
New Microbiol; 2016 Jul; 39(3):186-191. PubMed ID: 27284983
[TBL] [Abstract][Full Text] [Related]
32. Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation.
Tong CY; Cuevas LE; Williams H; Bakran A
J Clin Microbiol; 2000 Mar; 38(3):1209-13. PubMed ID: 10699024
[TBL] [Abstract][Full Text] [Related]
33. CMV infection, diagnosis and antiviral strategies after liver transplantation.
Lautenschlager I
Transpl Int; 2009 Nov; 22(11):1031-40. PubMed ID: 19619175
[TBL] [Abstract][Full Text] [Related]
34. Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study Group.
Falagas ME; Snydman DR; Ruthazer R; Werner BG; Griffith J
Clin Infect Dis; 1997 May; 24(5):824-9. PubMed ID: 9142776
[TBL] [Abstract][Full Text] [Related]
35. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.
Gentile G; Picardi A; Capobianchi A; Spagnoli A; Cudillo L; Dentamaro T; Tendas A; Cupelli L; Ciotti M; Volpi A; Amadori S; Martino P; de Fabritiis P
BMC Infect Dis; 2006 Nov; 6():167. PubMed ID: 17118205
[TBL] [Abstract][Full Text] [Related]
36. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
37. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
38. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
39. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542
[TBL] [Abstract][Full Text] [Related]
40. Viral factors influencing the outcome of human cytomegalovirus infection in liver transplant recipients.
Scott GM; Naing Z; Pavlovic J; Iwasenko JM; Angus P; Jones R; Rawlinson WD
J Clin Virol; 2011 Aug; 51(4):229-33. PubMed ID: 21641274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
